SPGI vs. NVO
SPGI (S&P Global Inc.) and NVO (Novo Nordisk A/S) are both stocks. SPGI operates in Financial Data & Stock Exchanges (Financial Services), while NVO operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, SPGI returned 16.05%/yr vs 8.18%/yr for NVO. At a 0.28 correlation, their price movements are largely independent.
Performance
SPGI vs. NVO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SPGI achieves a -8.87% return, which is significantly lower than NVO's 0.91% return. Over the past 10 years, SPGI has outperformed NVO with an annualized return of 16.05%, while NVO has yielded a comparatively lower 8.18% annualized return.
SPGI
- 1D
- -0.55%
- 1M
- 15.35%
- 6M
- -12.84%
- YTD
- -8.87%
- 1Y
- -8.85%
- 3Y*
- 4.69%
- 5Y*
- 3.46%
- 10Y*
- 16.05%
- ALL TIME*
- 13.43%
NVO
- 1D
- -1.41%
- 1M
- 14.86%
- 6M
- -17.63%
- YTD
- 0.91%
- 1Y
- -19.26%
- 3Y*
- -13.51%
- 5Y*
- 4.43%
- 10Y*
- 8.18%
- ALL TIME*
- 14.52%
SPGI vs. NVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SPGI S&P Global Inc. | -8.87% | 5.71% | 13.94% | 32.79% | -28.38% | 44.68% | 21.40% | 62.27% | 1.37% | 59.32% |
NVO Novo Nordisk A/S | 0.91% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 28.70% | -12.98% | 52.92% |
Correlation
The correlation between SPGI and NVO is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.25 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.31 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.31 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2001 | 0.28 |
The correlation between SPGI and NVO shifts across timeframes, from 0.16 (1 year) to 0.31 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
SPGI:
$132.71B
NVO:
$220.46B
SPGI:
$15.85
NVO:
DKK 27.42
SPGI:
28.29
NVO:
11.83
SPGI:
3.70
NVO:
0.51
SPGI:
8.59
NVO:
4.40
SPGI:
4.26
NVO:
7.11
SPGI:
$15.73B
NVO:
DKK 327.80B
SPGI:
$8.15B
NVO:
DKK 268.30B
SPGI:
$7.83B
NVO:
DKK 181.54B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SPGI vs. NVO — Risk / Return Rank
SPGI
NVO
SPGI vs. NVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for S&P Global Inc. (SPGI) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SPGI | NVO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.08 | ||
| Sortino ratioReturn per unit of downside risk | -0.01 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 0.97 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | -0.29 | -0.39 | +0.10 |
| Martin ratioReturn relative to average drawdown | -0.51 | -0.61 | +0.10 |
Loading charts...
Drawdowns
SPGI vs. NVO - Drawdown Comparison
The maximum SPGI drawdown since its inception was -74.67%, roughly equal to the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for SPGI and NVO.
Loading charts...
Drawdown Indicators
| SPGI | NVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -74.67% | -74.70% | +0.03% |
Max Drawdown (1Y)Largest decline over 1 year | -30.48% | -49.17% | +18.69% |
Max Drawdown (3Y)Largest decline over 3 years | -30.48% | -74.70% | +44.22% |
Max Drawdown (5Y)Largest decline over 5 years | -39.76% | -74.70% | +34.94% |
Max Drawdown (10Y)Largest decline over 10 years | -39.76% | -74.70% | +34.94% |
Current DrawdownCurrent decline from peak | -15.27% | -63.95% | +48.68% |
Average DrawdownAverage peak-to-trough decline | -15.25% | -17.89% | +2.64% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.44% | 31.75% | -14.31% |
Volatility
SPGI vs. NVO - Volatility Comparison
S&P Global Inc. (SPGI) has a higher volatility of 11.70% compared to Novo Nordisk A/S (NVO) at 9.48%. This indicates that SPGI's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SPGI | NVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.70% | 9.48% | +2.22% |
Volatility (6M)Calculated over the trailing 6-month period | 26.55% | 37.43% | -10.88% |
Volatility (1Y)Calculated over the trailing 1-year period | 30.16% | 51.79% | -21.63% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.06% | 38.58% | -13.52% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 26.15% | 32.63% | -6.48% |
Dividends
SPGI vs. NVO - Dividend Comparison
SPGI's dividend yield for the trailing twelve months is around 5.78%, more than NVO's 3.63% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | 3.63% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
SPGI S&P Global Inc. | 5.78% | 0.73% | 0.73% | 0.82% | 0.99% | 0.65% | 0.82% | 0.84% | 1.18% | 0.97% | 1.34% | 1.34% |
Financials
SPGI vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between S&P Global Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SPGI vs. NVO - Profitability Comparison
SPGI - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, S&P Global Inc. reported a gross profit of 0.00 and revenue of 4.17B. Therefore, the gross margin over that period was 0.0%.
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.
SPGI - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, S&P Global Inc. reported an operating income of 2.00B and revenue of 4.17B, resulting in an operating margin of 48.0%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.
SPGI - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, S&P Global Inc. reported a net income of 1.40B and revenue of 4.17B, resulting in a net margin of 33.5%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.
Frequently Asked Questions
SPGI and NVO have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SPGI has higher volatility (11.70%) compared to NVO (9.48%). In terms of maximum drawdown, SPGI dropped -74.67% vs NVO's -74.70%.
SPGI currently has the higher Sharpe Ratio (-0.29 vs -0.37), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SPGI and NVO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer